Screener
Vaxcyte, Inc. PCVX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $260,843 | $173,959 |
| Short-term investments | 1,476,335 | 1,387,000 |
| Prepaid expenses and other current assets | 76,310 | 66,402 |
| Total current assets | 1,813,488 | 1,627,361 |
| Property and equipment, net | 260,695 | 257,370 |
| Operating lease right-of-use assets | 113,103 | 116,009 |
| Long-term investments | 1,004,017 | 881,664 |
| Restricted cash | 1,466 | 1,466 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s total current assets?
- Vaxcyte, Inc. (PCVX) reported total current assets of $1.81B in Q1 2026.
- How has Vaxcyte, Inc.'s total current assets changed year-over-year?
- Vaxcyte, Inc.'s total current assets increased by 5.6% year-over-year, from $1.72B to $1.81B.
- What is the long-term trend for Vaxcyte, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total current assets has grown at a 33.1% compound annual growth rate (CAGR), from $389M to $1.63B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Vaxcyte, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude